Jump to main content
Jump to site search


Cyclodextrin-based sustained gene release systems: a supramolecular solution towards clinical applications

Author affiliations

Abstract

Recently, sustained release vectors, especially cyclodextrin (CD) based supramolecular carriers, have been reported to play an important role and have spurred interesting developments as novel gene delivery systems. This review will summarize the recent designs of CD-based supramolecular structures as sustained gene release systems in terms of CD-based graft copolymers, polyrotaxanes or polypseudorotaxanes, and supramolecular hydrogels; the advantages of these CD-based supramolecular carriers in terms of biocompatibility, gene transfection ability and controllable release rate by tuning the de-threading of CDs; and the applications of these CD-based supramolecular sustained gene release systems in disease treatments by taking advantage of their increase of the therapeutic gene's treatment period, thereby improving the gene transfection efficiency and avoiding repeated administration to increase patient compliance. Last but not least, the further endeavour towards CD-based supramolecular structures as more precise sustained gene release systems will also be discussed.

Graphical abstract: Cyclodextrin-based sustained gene release systems: a supramolecular solution towards clinical applications

Back to tab navigation

Publication details

The article was received on 06 Nov 2018, accepted on 25 Nov 2018 and first published on 26 Nov 2018


Article type: Review Article
DOI: 10.1039/C8QM00570B
Citation: Mater. Chem. Front., 2019, Advance Article
  •   Request permissions

    Cyclodextrin-based sustained gene release systems: a supramolecular solution towards clinical applications

    C. Xu, Y. Wu, Z. Li and X. J. Loh, Mater. Chem. Front., 2019, Advance Article , DOI: 10.1039/C8QM00570B

Search articles by author

Spotlight

Advertisements